REVEAL-SCAN Study is Recruiting

The goal of this study is to learn about the best ways to communicate and educate people about their risk of developing Alzheimer's Disease.
11/22/2016

The Risk Evaluation and Education for Alzheimer’s Disease: the Study of Communicating Amyloid Neuroimaging, or REVEAL-SCAN, study is a National Institutes of Health study being conducted at multiple sites in the US, including here at Michigan. The purpose of the study is to investigate how people respond to learning their risk of Alzheimer’s disease dementia and the result of their brain PET scan. We are interested in enrolling healthy adults between the ages of 65-80 years old with a family history of Alzheimer’s disease.

As part of our study, a brain PET scan will be conducted to detect the presence of a biomarker call amyloid. Amyloid is a protein that may build up in the brain and is believed to be associated with Alzheimer’s disease dementia. Participants will have the opportunity to come in and meet with a study clinician to learn about Alzheimer’s disease, amyloid, and their risk for developing Alzheimer’s disease. Each participant will receive an estimated risk for Alzheimer’s disease by age 85, and the results of an amyloid PET scan. Some participants will learn the result of their PET scan towards the beginning of the study, while others will learn it at the end of the study. 

For more information, please visit the REVEAL-SCAN Project Page

Please direct inquiries to revealscan@umich.edu